Civic Intelligence

Bioadvance DBA the Biotechnology Greenhouse of Southeastern Pennsylvania

990 • Fiscal year 2017 • EIN 46-0481876

Jul 01, 2016 to Jun 30, 2017 • Filed on Mar 19, 2018

Organization ProfileWWW.BIOADVANCE.COM

View Organization Page

170 N Radnor-chester Road No 350Radnor, PA 19087

(610) 230-0536

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

9th percentile

0.01x

Higher debt load relative to assets than 9% of similar nonprofits.

2017 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2017

Liabilities / Revenue

36th percentile

0.24x

Higher debt load relative to revenue than 36% of similar nonprofits.

2017 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2017

Net Margin

78th percentile

20%

Higher net margin than 78% of similar nonprofits.

2017 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2017

Top Officer Pay

47th percentile

$326,017

Higher top officer pay than 47% of similar nonprofits.

Top officer pay equals 12.8% of source-year revenue.

2017 filings • 501(c)3 • $50M-$100M nonprofits • Source year 2017

Asset Growth

22nd percentile

-0.7%

Faster asset growth than 22% of similar nonprofits.

2017 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2016 to 2017

Revenue Growth

1st percentile

-93%

Faster revenue growth than 1% of similar nonprofits.

2017 filings • 501(c)3 • $50M-$100M nonprofits • Annualized from 2016 to 2017

Balance Sheet
Liabilities / Assets9th percentile

Assets

Down

$60,962,570

Down $410,431 (-0.7%) from 2016

Net Assets

Down

$60,354,401

Down $404,366 (-0.7%) from 2016

Liabilities

Down

$608,169

Down $6,065 (-1.0%) from 2016

Revenue And Expenses
Liabilities / Revenue36th percentileNet Margin78th percentile

Revenue

Down

$2,547,864

Down $34,021,086 (-93%) from 2016

Expenses

Up

$2,048,992

Up $51,298 (+2.6%) from 2016

Net Income

Down

$498,872

Down $34,072,384 (-99%) from 2016

Historical Trend

Balance Sheet Trend

Asset Growth22nd percentile

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$100M$50M$0Assets 2010: $27,741,940Liabilities 2010: $477,969Net Assets 2010: $27,263,9712010Assets 2011: $27,011,673Liabilities 2011: $364,805Net Assets 2011: $26,646,8682011Assets 2012: $25,630,285Liabilities 2012: $540,305Net Assets 2012: $25,089,9802012Assets 2013: $26,647,958Liabilities 2013: $322,982Net Assets 2013: $26,324,9762013Assets 2014: $31,553,912Liabilities 2014: $465,297Net Assets 2014: $31,088,6152014Assets 2015: $28,978,459Liabilities 2015: $276,446Net Assets 2015: $28,702,0132015Assets 2016: $61,373,001Liabilities 2016: $614,234Net Assets 2016: $60,758,7672016Assets 2017: $60,962,570Liabilities 2017: $608,169Net Assets 2017: $60,354,4012017Assets 2018: $60,326,743Liabilities 2018: $637,973Net Assets 2018: $59,688,7702018Assets 2019: $66,045,472Liabilities 2019: $611,198Net Assets 2019: $65,434,2742019Assets 2020: $78,551,910Liabilities 2020: $650,521Net Assets 2020: $77,901,3892020Assets 2021: $80,190,811Liabilities 2021: $424,660Net Assets 2021: $79,766,1512021Assets 2022: $73,104,917Liabilities 2022: $301,566Net Assets 2022: $72,803,3512022Assets 2023: $81,948,557Liabilities 2023: $4,605,680Net Assets 2023: $77,342,8772023

Highlighted filing

2017

Assets$60,962,570
Liabilities$608,169
Net Assets$60,354,401
Open 2017 Filing

Operations Trend

Revenue Growth1st percentile

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$40M$30M$20M$10M$0-$10MExpenses 2010: $2,263,8742010Revenue 2011: $1,054,718Expenses 2011: $2,129,907Net Income 2011: -$1,075,1892011Expenses 2012: $2,039,6442012Expenses 2013: $2,040,1512013Revenue 2014: $5,921,552Expenses 2014: $1,989,408Net Income 2014: $3,932,1442014Revenue 2015: $1,845,392Expenses 2015: $1,954,957Net Income 2015: -$109,5652015Revenue 2016: $36,568,950Expenses 2016: $1,997,694Net Income 2016: $34,571,2562016Revenue 2017: $2,547,864Expenses 2017: $2,048,992Net Income 2017: $498,8722017Revenue 2018: $2,635,201Expenses 2018: $2,254,734Net Income 2018: $380,4672018Revenue 2019: $2,558,906Expenses 2019: $2,427,191Net Income 2019: $131,7152019Revenue 2020: $12,959,074Expenses 2020: $2,328,525Net Income 2020: $10,630,5492020Revenue 2021: $2,931,752Expenses 2021: $2,412,456Net Income 2021: $519,2962021Revenue 2022: $2,523,586Expenses 2022: $2,278,521Net Income 2022: $245,0652022Revenue 2023: $1,586,292Expenses 2023: $2,508,519Net Income 2023: -$922,2272023

Highlighted filing

2017

Revenue$2,547,864
Expenses$2,048,992
Net Income$498,872
Open 2017 Filing
Jump To
Filing Snapshot
Filing Period
Jul 1, 2016 to Jun 30, 2017
Signed
Mar 19, 2018
Return Version
2016v3.0
Gross Receipts
$36,220,311
Mission and Program Overview

Mission

The biotechnology greenhouse of southeastern pennsylvania was established with funds from the commonwealth of pennsylvania's share of the national tobacco settlement to accelerate growth of the life sciences industry by transforming the southeast pennsylvania region's strength in biomedical research and development into commercial opportunities. Approximately $25 million of the original government grant funding has been dedicated for pre-seed or "gap" funding for promising therapeutic, biomedical device and related technology companies, in a program called the greenhouse fund. The greenhouse fund is designed to move promising scientific projects out of the laboratory and into commercial opportunities. Additional funds were set aside for initiatives to increase the region's strengths in biomedical informatics and clinical trials.

Balance Sheet Detail
LineBeginningEndChange
Assets
Investments in Publicly Traded Securities$29,088,558$32,094,792▲ $3,006,234
Savings and Temporary Cash Investments$18,653,930$17,248,925▼ $1,405,005
Investments Program Related$9,233,061$11,206,796▲ $1,973,735
Prepaid Expenses and Deferred Charges$173,172$192,841▲ $19,669
Accounts Receivable$4,078,892$122,944▼ $3,955,948
Land, Buildings, and Equipment, Net$145,238$96,122▼ $49,116
Cash and Non-Interest-Bearing Accounts$150$150→ $0
Total Assets$61,373,001$60,962,570▼ $410,431
Liabilities
Accounts Payable and Accrued Expenses$376,139$366,503▼ $9,636
Deferred Revenue$238,095$241,666▲ $3,571
Total Liabilities$614,234$608,169▼ $6,065
Net Assets / Fund Balance
Unrestricted Net Assets$60,758,767$60,354,401▼ $404,366
Total Net Assets Fund Balance$60,758,767$60,354,401▼ $404,366
Total Liabilities and Net Assets / Fund Balance$61,373,001$60,962,570▼ $410,431

Asset Categories

AssetBook ValueDepreciationBasis
Leasehold Improvements$64,024$101,904$165,928
Equipment$32,098$67,215$99,313
Investment Program Related Org$5,849,004--
Compensation and Service Providers
Top Officer Pay47th percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Shahram HejaziTreasurerPT$255,831$70,186$326,017
Barbara S SchilbergCEO & Managing DirectorFT$265,000$44,882$309,882
Greg HarrimanVenture PartnerPT$188,728$52,237$240,965
Robert DriscollDirector of FinanceFT$165,306$51,410$216,716
Marnie MccoyProgram DirectorFT$113,906$10,782$124,688

Board Members and Trustees

NameTitle
J Larry Jameson Md PhdDirector
John Daly MdDirector
John GillDirector
Lauren LenfestDirector
Manuel StamatakisDirector
Philip Gerbino PharmdDirector
Russel Kaufman MdDirector
Sheri CollinsDirector
Steven Nichtberger MdDirector
Revenue and Support

Revenue Composition

Contributions and Grants
$1,479,166
Program Service Revenue
$402,533
Investment Income
$440,115
Other Revenue
$226,050
Change in Net Assets
$498,872

Audited Revenue Reconciliation

Revenue per Audited Statements
$2,148,013
Revenue Not Reported on Financial Statements
$399,851
Revenue Not Reported on Form 990
$0
Other Revenue Adjustments
$399,851
Total Revenue per Audited Statements
$2,148,013
Total Revenue per Form 990
$2,547,864
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Salaries, Compensation, and Employee Benefits$1,321,251
Other Expenses$727,741
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Current Officers, Directors, Trustees, and Key Employees$608,171$189,722-$797,893
Other Salaries and Wages$196,461$221,835-$418,296
Occupancy-$230,517-$230,517
Fees for Services Other$144,615$15,938-$160,553
Insurance-$63,602-$63,602
Payroll Taxes$34,025$18,190-$52,215
Other Employee Benefits$18,666$25,196-$43,862
Fees for Services Accounting-$42,800-$42,800
Depreciation Depletion-$39,133-$39,133
Information Technology-$35,966-$35,966
Fees for Services Lobbying-$26,208-$26,208
Fees for Services Legal$24,456$1,206-$25,662
Office Expenses-$19,396-$19,396
All Other Expenses-$15,308-$15,308
Pension Plan Contributions$3,651$5,334-$8,985
Other Expenses$32,789$5,900-$5,900
Travel-$3,748-$3,748
Conferences and Meetings-$2,907-$2,907
Fees for Service Investment Mgmnt Fees-$235-$235
Total Functional Expenses$1,062,834$986,158$0$2,048,992

Audited Expense Reconciliation

Line ItemAmount
Expenses per Audited Statements$2,048,992
Total Expenses per Audited Statements$2,048,992
Total Expenses per Form 990$2,048,992
Expenses Not Reported on Financial Statements$0
Expenses Not Reported on Form 990$0
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
Yes
Subject to proxy tax
No
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Annual disclosure for covered persons
Yes
Audit committee
Yes
Backup withholding compliance
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
Yes
Other officer compensation reviewed
Yes
Conflict-of-interest policy
Yes
Audited financial statements prepared
Yes
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Part VI, Section B, Line 11B

“Before the form 990 is filed with the irs, the form is distributed to the organization's board of directors for their review and comments.”

Form 990, Part VI, Section B, Line 12C

“Annually, the organization has its employees and board of directors sign a conflict of interest statement.”

Form 990, Part VI, Section B, Line 15

“Bioadvance recommended to the organization's compensation committee of the board of directors the salary increase for its ceo and officers for the year. After review and discussion, the compensation committee of the board of directors determined the appropriate salary increases.”

Form 990, Part VI, Section C, Line 19

“The organization's governing documents, conflict of interest policy and financial statements are available upon request.”

Filing and Contact Details

Filer

Filer Name
Bioadvance Dba the Biotechnology
EIN
46-0481876
Phone
6102300536
Address
170 N RADNOR-CHESTER ROAD NO 350, RADNOR, PA 19087
Doing Business As
The Biotechnology Greenhouse of Southeastern Pennsylvania

Signing Officer

Name
Barbara S Schilberg
Title
Managing Director & CEO
Phone
6102300536
Signed
2018-03-19
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Barbara S Schilberg
Formed
2002
Legal Domicile
Pa
Voting Board Members
10
Independent Board Members
9
Employees
5
Volunteers
0

Preparer

Firm
Eisneramper Llp
Address
130 NORTH 18TH STREET SUITE 3000, PHILADELPHIA, PA 19103-2757
Preparer
Helen M Martin
Phone
2158818800
Supplemental Narrative

Additional Explanations

FORM 990, PART XI, LINE 9:

“Unrealized loss on portfolio investments -1,101,147.”

FORM 990, PART XII, LINE 2C:

“The board of directors assumes the responsibility for oversight of the audit of its financial statements and the selection of an independent accountant. This process remains unchanged from the prior year.”

Financial Statement Notes

PART X, LINE 2:

“The internal revenue service has classified bioadvance as exempt from federal income taxes under section 501(c)(3) of the internal revenue code. Accounting principles generally accepted in the united states of america require management to evaluate tax positions taken and recognize a tax liability, if bioadvance has taken an uncertain tax position that more likely than not would not be sustained upon examination by a government authority. Management has analyzed the tax positions taken by bioadvance and has concluded that as of june 30, 2017 and 2016, there are no uncertain tax positions taken or expected to be taken that would require recognition of a liability or disclosure in the consolidated financial statements. Bioadvance recognizes interest and penalties associated with income taxes, if any, as part of interest and administrative expenses. There were no income tax related interest and penalties recorded for the years ended june 30, 2017 and 2016.”

PART XI, LINE 4B - OTHER ADJUSTMENTS:

“Realized loss on cash investments -2,682. Realized gain on portfolio investments 402,533.”

Raw XML AppendixShowing 400 of 633 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd00
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt0376139
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt0366503
IRS990/AccountsReceivableGrp/BOYAmt04078892
IRS990/AccountsReceivableGrp/EOYAmt0122944
IRS990/ActivitiesConductedPrtshpInd00
IRS990/ActivityOrMissionDesc0THE BIOTECHNOLOGY GREENHOUSE OF SOUTHEASTERN PENNSYLVANIA WAS ESTABLISHED WITH FUNDS FROM THE COMMONWEALTH OF PENNSYLVANIA'S SHARE OF THE NATIONAL TOBACCO SETTLEMENT TO ACCELERATE GROWTH OF THE LIFE SCIENCES INDUSTRY BY TRANSFORMING THE SOUTHEAST PENNSYLVANIA REGION'S STRENGTH IN BIOMEDICAL RESEARCH AND DEVELOPMENT INTO COMMERCIAL OPPORTUNITIES. APPROXIMATELY $25 MILLION OF THE ORIGINAL GOVERNMENT GRANT FUNDING HAS BEEN DEDICATED FOR PRE-SEED OR "GAP" FUNDING FOR PROMISING THERAPEUTIC, BIOMEDICAL DEVICE AND RELATED TECHNOLOGY COMPANIES, IN A PROGRAM CALLED THE GREENHOUSE FUND. THE GREENHOUSE FUND IS DESIGNED TO MOVE PROMISING SCIENTIFIC PROJECTS OUT OF THE LABORATORY AND INTO COMMERCIAL OPPORTUNITIES. ADDITIONAL FUNDS WERE SET ASIDE FOR INITIATIVES TO INCREASE THE REGION'S STRENGTHS IN BIOMEDICAL INFORMATICS AND CLINICAL TRIALS.
IRS990/AllOtherExpensesGrp/ManagementAndGeneralAmt015308
IRS990/AllOtherExpensesGrp/TotalAmt015308
IRS990/AnnualDisclosureCoveredPrsnInd01
IRS990/AuditCommitteeInd01
IRS990/BackupWthldComplianceInd00
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ROBERT DRISCOLL DIRECTOR OF FINANCE
IRS990/BooksInCareOfDetail/PhoneNum06102300536
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt0170 N RADNOR-CHESTER ROAD SUITE 350
IRS990/BooksInCareOfDetail/USAddress/CityNm0RADNOR
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd019087
IRS990/BusinessRlnWithFamMemInd00
IRS990/BusinessRlnWithOfficerEntInd00
IRS990/BusinessRlnWithOrgMemInd00
IRS990/CashNonInterestBearingGrp/BOYAmt0150
IRS990/CashNonInterestBearingGrp/EOYAmt0150
IRS990/ChangeToOrgDocumentsInd00
IRS990/CntrctRcvdGreaterThan100KCnt00
IRS990/CollectionsOfArtInd00
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt0189722
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt0608171
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0797893
IRS990/CompensationFromOtherSrcsInd00
IRS990/CompensationProcessCEOInd01
IRS990/CompensationProcessOtherInd01
IRS990/ConferencesMeetingsGrp/ManagementAndGeneralAmt02907
IRS990/ConferencesMeetingsGrp/TotalAmt02907
IRS990/ConflictOfInterestPolicyInd01
IRS990/ConservationEasementsInd00
IRS990/ConsolidatedAuditFinclStmtInd01
IRS990/CreditCounselingInd00
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt01479166
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt0440115
IRS990/CYOtherExpensesAmt0727741
IRS990/CYOtherRevenueAmt0226050
IRS990/CYProgramServiceRevenueAmt0402533
IRS990/CYRevenuesLessExpensesAmt0498872
IRS990/CYSalariesCompEmpBnftPaidAmt01321251
IRS990/CYTotalExpensesAmt02048992
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt02547864
IRS990/DecisionsSubjectToApprovaInd00
IRS990/DeductibleArtContributionInd00
IRS990/DeductibleNonCashContriInd00
IRS990/DeferredRevenueGrp/BOYAmt0238095
IRS990/DeferredRevenueGrp/EOYAmt0241666
IRS990/DelegationOfMgmtDutiesInd00
IRS990/DepreciationDepletionGrp/ManagementAndGeneralAmt039133
IRS990/DepreciationDepletionGrp/TotalAmt039133
IRS990/Desc0GREENHOUSE PROGRAM - THE CORNERSTONE OF BIOADVANCE INVESTMENT ACTIVITIES - WAS LAUNCHED TWO MONTHS AFTER RECEIVING THE DCED GRANT. THE PROGRAM FUNDS YOUNG COMPANIES FOR 'PROOF OF CONCEPT' WORK THAT WITHIN 24 MONTHS WILL PROVIDE ENOUGH SCIENTIFIC PROGRESS TO ENABLE THEM TO ATTRACT VENTURE CAPITAL OR AN INDUSTRY PARTNER. INDIVIDUAL COMPANIES ARE ELIGIBLE TO RECEIVE UP TO $1,500,000 WHICH IS DISBURSED AS MILESTONES ARE ACHIEVED, UNLESS THE CAP IS INCREASED BY THE BOARD. THE INVESTMENTS ARE IN THE FORM OF A NOTE THAT CONVERTS INTO EQUITY UPON A SPECIFIED MINIMUM SIZE OF DOLLAR FUNDING.
IRS990/DescribedInSection501c3Ind01
IRS990/DisregardedEntityInd00
IRS990/DocumentRetentionPolicyInd01
IRS990/DoingBusinessAsName/BusinessNameLine1Txt0THE BIOTECHNOLOGY GREENHOUSE OF SOUTHEASTERN PENNSYLVANIA
IRS990/DonorAdvisedFundInd00
IRS990/ElectionOfBoardMembersInd00
IRS990/EmployeeCnt05
IRS990/EmploymentTaxReturnsFiledInd01
IRS990/EngagedInExcessBenefitTransInd00
IRS990/ExpenseAmt01062834
IRS990/FamilyOrBusinessRlnInd00
IRS990/FederalGrantAuditRequiredInd00
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt042800
IRS990/FeesForServicesAccountingGrp/TotalAmt042800
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt01206
IRS990/FeesForServicesLegalGrp/ProgramServicesAmt024456
IRS990/FeesForServicesLegalGrp/TotalAmt025662
IRS990/FeesForServicesLobbyingGrp/ManagementAndGeneralAmt026208
IRS990/FeesForServicesLobbyingGrp/TotalAmt026208
IRS990/FeesForServicesOtherGrp/ManagementAndGeneralAmt015938
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt0144615
IRS990/FeesForServicesOtherGrp/TotalAmt0160553
IRS990/FeesForSrvcInvstMgmntFeesGrp/ManagementAndGeneralAmt0235
IRS990/FeesForSrvcInvstMgmntFeesGrp/TotalAmt0235
IRS990/ForeignActivitiesInd00
IRS990/ForeignFinancialAccountInd00
IRS990/ForeignOfficeInd00
IRS990/Form8282PropertyDisposedOfInd00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt10.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt20.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt30.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt40.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt50.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt60.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt70.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt80.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt90.50
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1032.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1124.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1240.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt1340.00
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd0X
IRS990/Form990PartVIISectionAGrp/HighestCompensatedEmployeeInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd5X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd6X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd7X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd8X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd9X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt024882
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt50
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt60
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt70
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt80
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt90
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1034186
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1125637
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1235410
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt1310782
IRS990/Form990PartVIISectionAGrp/PersonNm0BARBARA S SCHILBERG
IRS990/Form990PartVIISectionAGrp/PersonNm1J LARRY JAMESON MD PHD
IRS990/Form990PartVIISectionAGrp/PersonNm2JOHN DALY MD
IRS990/Form990PartVIISectionAGrp/PersonNm3PHILIP GERBINO PHARMD
IRS990/Form990PartVIISectionAGrp/PersonNm4JOHN GILL
IRS990/Form990PartVIISectionAGrp/PersonNm5RUSSEL KAUFMAN MD
IRS990/Form990PartVIISectionAGrp/PersonNm6STEVEN NICHTBERGER MD
IRS990/Form990PartVIISectionAGrp/PersonNm7LAUREN LENFEST
IRS990/Form990PartVIISectionAGrp/PersonNm8MANUEL STAMATAKIS
IRS990/Form990PartVIISectionAGrp/PersonNm9SHERI COLLINS
IRS990/Form990PartVIISectionAGrp/PersonNm10SHAHRAM HEJAZI
IRS990/Form990PartVIISectionAGrp/PersonNm11GREG HARRIMAN
IRS990/Form990PartVIISectionAGrp/PersonNm12ROBERT DRISCOLL
IRS990/Form990PartVIISectionAGrp/PersonNm13MARNIE MCCOY
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt0285000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt10291831
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt11215328
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt12181306
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt13113906
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt50
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt60
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt70
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt80
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt90
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt100
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt110
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt120
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt130
IRS990/Form990PartVIISectionAGrp/TitleTxt0CEO & MANAGING DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt1DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt2DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt5DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt6DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt7DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt8DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt9DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt10TREASURER
IRS990/Form990PartVIISectionAGrp/TitleTxt11VENTURE PARTNER
IRS990/Form990PartVIISectionAGrp/TitleTxt12DIRECTOR OF FINANCE
IRS990/Form990PartVIISectionAGrp/TitleTxt13PROGRAM DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd01
IRS990/FormationYr02002
IRS990/FormerOfcrEmployeesListedInd00
IRS990/FSAuditedBasisGrp/ConsolidatedBasisFinclStmtInd0X
IRS990/FSAuditedInd01
IRS990/FundraisingActivitiesInd00
IRS990/GainOrLossGrp/SecuritiesAmt0-2682
IRS990/GamingActivitiesInd00
IRS990/GoverningBodyVotingMembersCnt010
IRS990/GovernmentGrantsAmt01479166
IRS990/GrantsToIndividualsInd00
IRS990/GrantsToOrganizationsInd00
IRS990/GrantToRelatedPersonInd00
IRS990/GrossAmountSalesAssetsGrp/SecuritiesAmt033669765
IRS990/GrossReceiptsAmt036220311
IRS990/GroupReturnForAffiliatesInd00
IRS990/IncludeFIN48FootnoteInd01
IRS990/IndependentAuditFinclStmtInd00
IRS990/IndependentVotingMemberCnt09
IRS990/IndivRcvdGreaterThan100KCnt05
IRS990/IndoorTanningServicesInd00
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InfoInScheduleOPartXIIInd0X
IRS990/InfoInScheduleOPartXIInd0X
IRS990/InformationTechnologyGrp/ManagementAndGeneralAmt035966
IRS990/InformationTechnologyGrp/TotalAmt035966
IRS990/InsuranceGrp/ManagementAndGeneralAmt063602
IRS990/InsuranceGrp/TotalAmt063602
IRS990/InvestmentIncomeGrp/ExclusionAmt0397539
IRS990/InvestmentIncomeGrp/RelatedOrExemptFuncIncomeAmt045258
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt0442797
IRS990/InvestmentInJointVentureInd00
IRS990/InvestmentsProgramRelatedGrp/BOYAmt09233061
IRS990/InvestmentsProgramRelatedGrp/EOYAmt011206796
IRS990/InvestmentsPubTradedSecGrp/BOYAmt029088558
IRS990/InvestmentsPubTradedSecGrp/EOYAmt032094792
IRS990/IRPDocumentCnt017
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0169119
IRS990/LandBldgEquipBasisNetGrp/BOYAmt0145238
IRS990/LandBldgEquipBasisNetGrp/EOYAmt096122
IRS990/LandBldgEquipCostOrOtherBssAmt0265241
IRS990/LegalDomicileStateCd0PA
IRS990/LessCostOthBasisSalesExpnssGrp/SecuritiesAmt033672447
IRS990/LoanOutstandingInd00
IRS990/LobbyingActivitiesInd01
IRS990/LocalChaptersInd00
IRS990/MaterialDiversionOrMisuseInd00
IRS990/MembersOrStockholdersInd00
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd01
IRS990/MinutesOfGoverningBodyInd01
IRS990/MissionDesc0THE BIOTECHNOLOGY GREENHOUSE OF SOUTHEASTERN PENNSYLVANIA WAS ESTABLISHED WITH FUNDS FROM THE COMMONWEALTH OF PENNSYLVANIA'S SHARE OF THE NATIONAL TOBACCO SETTLEMENT TO ACCELERATE GROWTH OF THE LIFE SCIENCES INDUSTRY BY TRANSFORMING THE SOUTHEAST PENNSYLVANIA REGION'S STRENGTH IN BIOMEDICAL RESEARCH AND DEVELOPMENT INTO COMMERCIAL OPPORTUNITIES. APPROXIMATELY $25 MILLION OF THE ORIGINAL GOVERNMENT GRANT FUNDING HAS BEEN DEDICATED FOR PRE-SEED OR "GAP" FUNDING FOR PROMISING THERAPEUTIC, BIOMEDICAL DEVICE AND RELATED TECHNOLOGY COMPANIES, IN A PROGRAM CALLED THE GREENHOUSE FUND. THE GREENHOUSE FUND IS DESIGNED TO MOVE PROMISING SCIENTIFIC PROJECTS OUT OF THE LABORATORY AND INTO COMMERCIAL OPPORTUNITIES. ADDITIONAL FUNDS WERE SET ASIDE FOR INITIATIVES TO INCREASE THE REGION'S STRENGTHS IN BIOMEDICAL INFORMATICS AND CLINICAL TRIALS.
IRS990/MoreThan5000KToIndividualsInd00
IRS990/MoreThan5000KToOrgInd00
IRS990/NetAssetsOrFundBalancesBOYAmt060758767
IRS990/NetAssetsOrFundBalancesEOYAmt060354401
IRS990/NetGainOrLossInvestmentsGrp/ExclusionAmt0-2682
IRS990/NetGainOrLossInvestmentsGrp/TotalRevenueColumnAmt0-2682
IRS990/NetUnrelatedBusTxblIncmAmt00
IRS990/NetUnrlzdGainsLossesInvstAmt0197909
IRS990/NondeductibleContributionsInd00
IRS990/OccupancyGrp/ManagementAndGeneralAmt0230517
IRS990/OccupancyGrp/TotalAmt0230517
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt019396
IRS990/OfficeExpensesGrp/TotalAmt019396
IRS990/OfficerMailingAddressInd00
IRS990/OperateHospitalInd00
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherChangesInNetAssetsAmt0-1101147
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt025196
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt018666
IRS990/OtherEmployeeBenefitsGrp/TotalAmt043862
IRS990/OtherExpensesGrp/Desc0DUE DILIGENCE
IRS990/OtherExpensesGrp/Desc1MEMBERSHIPS
IRS990/OtherExpensesGrp/Desc2DUES AND SUBSCRIPTIONS
IRS990/OtherExpensesGrp/Desc3SPONSORSHIPS
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt013815
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt19202
IRS990/OtherExpensesGrp/ManagementAndGeneralAmt25900
IRS990/OtherExpensesGrp/ProgramServicesAmt032789
IRS990/OtherExpensesGrp/TotalAmt032789
IRS990/OtherExpensesGrp/TotalAmt113815
IRS990/OtherExpensesGrp/TotalAmt29202
IRS990/OtherExpensesGrp/TotalAmt35900
IRS990/OtherRevenueMiscGrp/BusinessCd0525990
IRS990/OtherRevenueMiscGrp/Desc0OTHER INCOME
IRS990/OtherRevenueMiscGrp/RelatedOrExemptFuncIncomeAmt052000
IRS990/OtherRevenueMiscGrp/TotalRevenueColumnAmt052000
IRS990/OtherRevenueTotalAmt052000
IRS990/OtherSalariesAndWagesGrp/ManagementAndGeneralAmt0221835
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0196461
IRS990/OtherSalariesAndWagesGrp/TotalAmt0418296
IRS990/PartialLiquidationInd00
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt018190
IRS990/PayrollTaxesGrp/ProgramServicesAmt034025
IRS990/PayrollTaxesGrp/TotalAmt052215
IRS990/PensionPlanContributionsGrp/ManagementAndGeneralAmt05334
IRS990/PensionPlanContributionsGrp/ProgramServicesAmt03651
IRS990/PensionPlanContributionsGrp/TotalAmt08985
IRS990/PoliticalCampaignActyInd00
IRS990/PrepaidExpensesDefrdChargesGrp/BOYAmt0173172
IRS990/PrepaidExpensesDefrdChargesGrp/EOYAmt0192841
IRS990/PrincipalOfficerNm0BARBARA S SCHILBERG
IRS990/ProfessionalFundraisingInd00
IRS990/ProgramServiceRevenueGrp/BusinessCd0525990
IRS990/ProgramServiceRevenueGrp/Desc0RETURN ON PROGRAM-RELATED INVESTM
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt0402533
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt0402533
IRS990/ProhibitedTaxShelterTransInd00
IRS990/PYBenefitsPaidToMembersAmt00
IRS990/PYContributionsGrantsAmt01457484
IRS990/PYExcessBenefitTransInd00
IRS990/PYGrantsAndSimilarPaidAmt00
IRS990/PYInvestmentIncomeAmt02046585
IRS990/PYOtherExpensesAmt0658013
IRS990/PYOtherRevenueAmt0234390
IRS990/PYProgramServiceRevenueAmt032830491
IRS990/PYRevenuesLessExpensesAmt034571256
IRS990/PYSalariesCompEmpBnftPaidAmt01339681
IRS990/PYTotalExpensesAmt01997694
IRS990/PYTotalProfFndrsngExpnsAmt00
IRS990/PYTotalRevenueAmt036568950
IRS990/QuidProQuoContributionsInd00
IRS990/ReconcilationRevenueExpnssAmt0498872
IRS990/RegularMonitoringEnfrcInd01
IRS990/RelatedEntityInd01
IRS990/RelatedOrganizationCtrlEntInd01
IRS990/ReportInvestmentsOtherSecInd00
IRS990/ReportLandBuildingEquipmentInd01
IRS990/ReportOtherAssetsInd00
IRS990/ReportOtherLiabilitiesInd00
IRS990/ReportProgramRelatedInvstInd01
IRS990/RevenueAmt0673841
IRS990/RoyaltiesRevenueGrp/RelatedOrExemptFuncIncomeAmt0174050
IRS990/RoyaltiesRevenueGrp/TotalRevenueColumnAmt0174050
IRS990/SavingsAndTempCashInvstGrp/BOYAmt018653930
IRS990/SavingsAndTempCashInvstGrp/EOYAmt017248925
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt01479166
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus1YearAmt01457484
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus2YearsAmt01060012
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus3YearsAmt0226178
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearMinus4YearsAmt01135558
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt05358398
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearAmt0616847
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus1YearAmt02248164
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus2YearsAmt0188668
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus3YearsAmt08265
IRS990ScheduleA/GrossInvestmentIncome170Grp/CurrentTaxYearMinus4YearsAmt01117800
IRS990ScheduleA/GrossInvestmentIncome170Grp/TotalAmt04179744
IRS990ScheduleA/GrossReceiptsRltdActivitiesAmt040505780
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.56180
IRS990ScheduleA/PublicSupportPY170Pct00.55200
IRS990ScheduleA/PublicSupportTotal170Amt05358398
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY170Ind0X
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt01479166
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus1YearAmt01457484
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus2YearsAmt01060012
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus3YearsAmt0226178
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearMinus4YearsAmt01135558
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt05358398
IRS990ScheduleA/TotalSupportAmt09538142
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd01
IRS990ScheduleC/DirectContactLegislatorsAmt025458
IRS990ScheduleC/DirectContactLegislatorsInd01
IRS990ScheduleC/GrantsOtherOrganizationsInd00
IRS990ScheduleC/MailingsMembersInd00
IRS990ScheduleC/MediaAdvertisementsInd00
IRS990ScheduleC/NotDescribedSection501c3Ind00
IRS990ScheduleC/OtherActivitiesInd00
IRS990ScheduleC/PaidStaffOrManagementInd00
IRS990ScheduleC/PublicationsOrBroadcastInd00
IRS990ScheduleC/RalliesDemonstrationsInd00
IRS990ScheduleC/SupplementalInformationDetail/ExplanationTxt0BIOADVANCE PAID GREENLEE PARTNERS LLC $25,458 FOR ITS SHARE OF FEES TO MEET WITH STATE LEGISLATORS TO ADVOCATE ON BEHALF OF BIOADVANCE AND TWO OTHER LIFE SCIENCE GREENHOUSES.
IRS990ScheduleC/SupplementalInformationDetail/FormAndLineReferenceDesc0PART II-B, LINE 1:
IRS990ScheduleC/TotalLobbyingExpendituresAmt025458
IRS990ScheduleC/VolunteersInd00
IRS990ScheduleD/EquipmentGrp/BookValueAmt032098
IRS990ScheduleD/EquipmentGrp/DepreciationAmt067215
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt099313
IRS990ScheduleD/ExpensesNotReportedAmt00
IRS990ScheduleD/ExpensesNotRptFinclStmtAmt00
IRS990ScheduleD/ExpensesSubtotalAmt02048992
IRS990ScheduleD/FootnoteTextInd0X
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt05334255
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt123537
IRS990ScheduleD/InvstProgramRelatedOrgGrp/BookValueAmt25849004
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc0COMMON & PREFERRED INVESTMENTS
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc1INVESTMENT IN PLSG ACCELERATOR
IRS990ScheduleD/InvstProgramRelatedOrgGrp/Desc2NOTES RECEIVABLE
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd0F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd1F
IRS990ScheduleD/InvstProgramRelatedOrgGrp/MethodValuationCd2F
IRS990ScheduleD/LeaseholdImprovementsGrp/BookValueAmt064024
IRS990ScheduleD/LeaseholdImprovementsGrp/DepreciationAmt0101904
IRS990ScheduleD/LeaseholdImprovementsGrp/OtherCostOrOtherBasisAmt0165928
IRS990ScheduleD/OtherRevenuesNotIncludedAmt0399851
IRS990ScheduleD/RevenueNotReportedAmt00
IRS990ScheduleD/RevenueNotReportedFinclStmtAmt0399851
IRS990ScheduleD/RevenueSubtotalAmt02148013
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt0THE INTERNAL REVENUE SERVICE HAS CLASSIFIED BIOADVANCE AS EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE. ACCOUNTING PRINCIPLES GENERALLY ACCEPTED IN THE UNITED STATES OF AMERICA REQUIRE MANAGEMENT TO EVALUATE TAX POSITIONS TAKEN AND RECOGNIZE A TAX LIABILITY, IF BIOADVANCE HAS TAKEN AN UNCERTAIN TAX POSITION THAT MORE LIKELY THAN NOT WOULD NOT BE SUSTAINED UPON EXAMINATION BY A GOVERNMENT AUTHORITY. MANAGEMENT HAS ANALYZED THE TAX POSITIONS TAKEN BY BIOADVANCE AND HAS CONCLUDED THAT AS OF JUNE 30, 2017 AND 2016, THERE ARE NO UNCERTAIN TAX POSITIONS TAKEN OR EXPECTED TO BE TAKEN THAT WOULD REQUIRE RECOGNITION OF A LIABILITY OR DISCLOSURE IN THE CONSOLIDATED FINANCIAL STATEMENTS. BIOADVANCE RECOGNIZES INTEREST AND PENALTIES ASSOCIATED WITH INCOME TAXES, IF ANY, AS PART OF INTEREST AND ADMINISTRATIVE EXPENSES. THERE WERE NO INCOME TAX RELATED INTEREST AND PENALTIES RECORDED FOR THE YEARS ENDED JUNE 30, 2017 AND 2016.
IRS990ScheduleD/SupplementalInformationDetail/ExplanationTxt1REALIZED LOSS ON CASH INVESTMENTS -2,682. REALIZED GAIN ON PORTFOLIO INVESTMENTS 402,533.

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Displayed year

2017 • Form 990Detailed filing. Detailed filing data is available for this year.

Open filing
Assets
$60,962,570
Liabilities
$608,169
Net assets
$60,354,401
Revenue
$2,547,864
Expenses
$2,048,992
Net income
$498,872
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2023Summary only. Only limited summary data is available for this year.$81.9$4.61$77.3$1.59$2.51$0.92
2022Summary only. Only limited summary data is available for this year.$73.1$0.30$72.8$2.52$2.28$0.25
2021Summary only. Only limited summary data is available for this year.$80.2$0.42$79.8$2.93$2.41$0.52
2020Summary only. Only limited summary data is available for this year.$78.6$0.65$77.9$13.0$2.33$10.6
2019Summary only. Only limited summary data is available for this year.$66.0$0.61$65.4$2.56$2.43$0.13
2018Summary only. Only limited summary data is available for this year.$60.3$0.64$59.7$2.64$2.25$0.38
2017Detailed filing. Detailed filing data is available for this year.$61.0$0.61$60.4$2.55$2.05$0.50
2016Summary only. Only limited summary data is available for this year.$61.4$0.61$60.8$36.6$2.00$34.6
2015Summary only. Only limited summary data is available for this year.$29.0$0.28$28.7$1.85$1.95$0.11
2014Summary only. Only limited summary data is available for this year.$31.6$0.47$31.1$5.92$1.99$3.93
2013Summary only. Only limited summary data is available for this year.$26.6$0.32$26.3$2.04
2012Summary only. Only limited summary data is available for this year.$25.6$0.54$25.1$2.04
2011Summary only. Only limited summary data is available for this year.$27.0$0.36$26.6$1.05$2.13$1.08
2010Summary only. Only limited summary data is available for this year.$27.7$0.48$27.3$2.26